Page 10 - Pharmaceutical Companies
Dr Reddy's to acquire part of Wockhardt's India business for Rs 1,850 crore
The agreement comprises a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, and dermatology.
 "Dr Reddy's to acquire part of Wockhardt's India business for Rs 1,850 crore")
Govt may impose anti-dumping duty on a Chinese medicine for infections
Aarti Drugs Ltd has filed an application before the directorate for investigation into the imports from the neighbouring country
 "Govt may impose anti-dumping duty on a Chinese medicine for infections")
Sun Pharma gets partial relief from US court in litigation on generic drugs
Shares of the company on Monday ended 2.18 per cent lower at Rs 440 apiece on the BSE
 "Sun Pharma gets partial relief from US court in litigation on generic drugs")
Biocon to set up R&D facility in India to boost biosimilars development
Biocon has acquired some assets from Pfizer Healthcare to set up its second R&D plant in India
 "Biocon to set up R&D facility in India to boost biosimilars development")
Indian companies giving MNCs a run for their money in vitamins
Three of top five pharmaceutical companies by market share based in India
 "Indian companies giving MNCs a run for their money in vitamins")
One year later, pharma industry bounces back to double-digit growth in May
In May, price growth for drugs was in negative territory at (-)1 per cent
 "One year later, pharma industry bounces back to double-digit growth in May")
Indian pharma's Chinese crisis: Firms fear profit hit on cost hikes
The high dependence on Chinese imports has also been dubbed as a health security risk
 "Indian pharma's Chinese crisis: Firms fear profit hit on cost hikes")
Nearly half of pharma industry may come under price control
DPCO 2013 that lists drugs under price control already includes 18 per cent drugs sold in domestic market
 "Nearly half of pharma industry may come under price control")
Staff shortage at regulator to stand in way of generic drugs push
Branded generics occupies 90% of the Rs 1-lakh cr pharma market in India
 "Staff shortage at regulator to stand in way of generic drugs push")
Top pharma firms get notices for overcharging
The authority maintained that it was witnessing a large number of non-compliance cases every month
 "Top pharma firms get notices for overcharging")
Drug firms facing big penalty may not go for settlement
NPPA has till date recovered only 7.8 per cent of fines related to overpricing; dues run in to Rs 3,698.32 crore
 "Drug firms facing big penalty may not go for settlement")